NIM
BMRN icon

NuWave Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

NuWave Investment Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$65K Buy
+761
New +$67.8K 0.07% 230
2022
Q2 		– Sell
-1,488
Closed -$115K – 261
2022
Q1 		$115K Buy
1,488
+628
+73% +$52.5K 0.15% 174
2021
Q4 		$76K Buy
+860
New +$71K 0.09% 219
2021
Q3 		– Sell
-2,527
Closed -$211K – 305
2021
Q2 		$211K Buy
2,527
+83
+3% +$6.58K 0.23% 139
2021
Q1 		$185K Buy
2,444
+2,068
+550% +$169K 0.23% 147
2020
Q4 		$33K Sell
376
-4,380
-92% -$347K 0.04% 266
2020
Q3 		$361K Buy
4,756
+4,728
+16,886% +$478K 0.55% 55
2020
Q2 		$3K Buy
+28
New +$2.78K ﹤0.01% 382
2020
Q1 		– Sell
-63
Closed -$5K – 224
2019
Q4 		$5K Sell
63
-2,873
-98% -$217K ﹤0.01% 369
2019
Q3 		$198K Buy
2,936
+2,750
+1,478% +$212K 0.2% 147
2019
Q2 		$16K Sell
186
-3,500
-95% -$299K 0.02% 317
2019
Q1 		$327K Buy
3,686
+3,591
+3,780% +$333K 0.38% 93
2018
Q4 		$8K Sell
95
-1,628
-94% -$155K 0.01% 274
2018
Q3 		$167K Buy
1,723
+1,719
+42,975% +$172K 0.25% 140
2018
Q2 		$0 Buy
+4
New +$350 ﹤0.01% 385
2018
Q1 		– Sell
-13
Closed -$1K – 241
2017
Q4 		$1K Buy
+13
New +$1.13K ﹤0.01% 327

Other funds holding BMRN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

NuWave Investment Management's BMRN Position: Q3 2022 in Review

NuWave Investment Management opened a new position in BioMarin Pharmaceuticals (BMRN) in Q3 2022: 761 shares worth $65K. The stake represents 0.07% of the portfolio and ranks #230 among its holdings. This is a return to the name: NuWave Investment Management previously reported a position in BMRN as recently as Q1 2022.

NuWave Investment Management first reported a position in BMRN in Q4 2017 and has held it in 16 quarters since. The position peaked at $361K in Q3 2020. 552 funds tracked by Wall St. Rank hold BMRN as of Q3 2022.

  • NuWave Investment Management held 761 shares of BioMarin Pharmaceuticals worth $65K as of Q3 2022.
  • BioMarin Pharmaceuticals was a new NuWave Investment Management position in Q3 2022.
  • BioMarin Pharmaceuticals made up 0.07% of NuWave Investment Management's portfolio in Q3 2022, its #230 holding.
  • NuWave Investment Management first reported a position in BioMarin Pharmaceuticals in Q4 2017 and has held it in 16 quarters since.
  • NuWave Investment Management's BioMarin Pharmaceuticals position peaked at $361K in Q3 2020.
  • 552 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2022.

Based on NuWave Investment Management's 13F filing for Q3 2022, filed 21 Oct 2022.